Brazil Grapples with Rise in Ozempic Robberies Amid Weight Loss Craze
Brazil’s booming appetite for weight-loss medications, particularly Ozempic, is fueling a worrying trend: an alarming increase in pharmacy robberies.
From São Paulo, the nation’s largest metropolis, to smaller cities, pharmacies are finding themselves increasingly targeted, particularly those dispensing the coveted medications.
“Drug medications” is increasingly a phrase that resonates deeply within the Brazilian pharmaceutical landscape, becoming synonymous with highly sought-after, yet increasingly inaccessible, medications like Ozempic, Wegovy, and Saxenda. Despite soaring obesity rates, the exorbitant costs of these drugs make them out of reach for many Brazilians.
Pharmacists find themselves caught between serving patients in desperate need and safeguarding their livelihoods.
Following a terrifying incident in August, where an attempted Ozempic robbery in São Paulo culminated in gunfire and an elderly woman’s injury, pharmacies across the city are scrambling to beef up security. Armed guards are now commonplace, stationed strategically throughout stores, adding an unsettling layer of vigilance to a profession typically characterized by community engagement.
While incidents are occurring globally, Brazil, specifically São Paulo, stands out as a hotspot. Its affluent neighborhoods, a plethora of pharmacies, and sophisticated criminal networks leveraging platforms like WhatsApp and Facebook have transformed these establishments into lucrative targets.
Pedro Ivo Corrêa Dos Santos, São Paulo’s Criminal Investigation Department chief, admits, "Thieves are undoubtedly on the rise." His sentiment is echoed by numerous pharmacies grappling with shrinking margins, reduced staff, and an escalating sense of fear.
While exact figures are difficult to obtain, analyses reveal a disturbing trend. São Paulo’s state database documents 18 Ozempic robberies in 2023, soaring to 39 in 2024. These figures, however, likely represent the tip of the iceberg, with numerous incidents failing to specify the stolen medications.
Chain pharmacies, particularly RD Saúde and Grupo DPS, are hesitant to discuss the issue, but the widespread impact on independent pharmacies is undeniable. Many are opting to eliminate Ozempic stock entirely, forcing customers to seek alternatives.
Wilson Martins, manager of Farma Imperator, a family-owned pharmacy, embodies the struggles faced by his peers. Facing the daily risk of robbery, Martins adopts proactive measures: denying customers Ozempic availability and employing a hidden machete as an unlikely deterrent.
Meanwhile, authorities reveal the shocking reach of organized criminal groups, who target not just pharmacies, but also Ozempic shipments en route.
Brazil’s drug regulator, Anvisa, receives consistent reports of pharmaceutical theft, revealing a complex challenge beyond individual store security.
This growing epidemic underscores a broader societal dilemma: access versus affordability. As Brazilians struggle with obesity and yearn for weight-loss solutions, criminal activity thrives on exploiting both demand and vulnerability.
The potential arrival of generic Ozempic versions in 2026, stemming from the expiration of Novo Nordisk’s Brazilian patent, offers a glimmer of hope. However, in the meantime, Brazil’s pharmacies face an uncertain future, navigating a delicate balance between meeting patient needs and ensuring their safety amidst a volatile market.